Madrid
Un artículo publicado
en The New York Times el pasado
martes podría acabar
con la cooperación económica
del laboratorio Pfizer con
una de las facultades de Medicina
más prestigiosas del
mundo, la de Harvard.
La historia comenzó el pasado
martes, cuando un grupo
de estudiantes de la universidad
se manifestaba precisamente
contra la influencia
de la industria farmacéutica
en la facultad. Los futuros
médicos observaron cómo
un hombre, que se identificó
a sí mismo como un empleado
del Pfizer, sacaba fotografías
de la manifestación
con su teléfono móvil.
Mas...
BOSTON — In a first-year pharmacology class at Harvard Medical School, Matt Zerden grew wary as the professor promoted the benefits of cholesterol drugs and seemed to belittle a student who asked about side effects
Mr. Zerden later discovered something by searching online that he began sharing with his classmates. The professor was not only a full-time member of the Harvard Medical faculty, but a paid consultant to 10 drug companies, including five makers of cholesterol treatments
Under the school’s disclosure rules, about 1,600 of 8,900 professors and lecturers have reported to the dean that they or a family member had a financial interest in a business related to their teaching, research or clinical care. The reports show 149 with financial ties to Pfizer and 130 with Merck.
Mas...
No hay comentarios:
Publicar un comentario